We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innovative Sterilizer Cycles Surgical Instruments in Just 6 Minutes

By LabMedica International staff writers
Posted on 30 Apr 2009
An ultrafast surgical instrument resterilization system could lower the overall cost of care by preventing infections resulting from surgery in large healthcare facilities, military field hospitals, and ambulatory surgical centers.

The Germgard Ozone resterilization system's six-minute total cycle time is much shorter than for hot steam sterilization or any other room-temperature, gas sterilant process, due to an innovative approach that utilizes ozone, a proven sterilant for centralized instrument sterilization. More...
The ability to inactivate 99.9999% of all pathogens, including spores, with room temperature techniques in just six minutes contributes to reduce instrument damage and enhance inventory turnaround, two critical considerations for operational efficiency. The instruments to be sterilized are placed in a single pouch or multi instrument kit, which is then sealed, becoming impervious to pathogens or gas flow. Ozone at a very high concentration is then continuously created from dry oxygen, and is maintained within the single instrument pouch or the kit. The sterilized instrument is available immediately upon termination of the sterilization process or can remain in the sterile pouch or kit until needed; no ozone leaves the sealed pouch, and the ozone itself is destroyed before the pouch or kit is opened. There is no handling or instrument exposure until used.

Potential applications of the system is for use in doctors and dentists offices, small surgical centers, military field hospitals, and emergency services, since the unit is smaller than conventional autoclave systems and overall is less expensive. The Germgard Ozone resterilization system is a product of Germgard Lighting (Dover, NJ, USA), and still requires an efficacy prove-in for premarket clearance in the United States by the U.S. Food and Drug Administration (FDA).

"Deployment of our efficacious, easy-to-use, and ultrafast sterilization products will be one of the least expensive, quickest to implement, and most effective means for healthcare facilities to immediately lower operating costs and properly protect patients undergoing surgery," said Eugene Gordon, CEO of Germgard. "Commercialization and implementation of this solution will positively impact infection prevention and resolve operational cost tradeoffs facing hospital CEOs."

Ozone generally requires a short contact time for complete disinfection by effectively oxidizing a variety of water borne contaminants, without leaving an undesirable residual or adding to total dissolved solids (TDS) levels. The ozone is manufactured using a high frequency electrical charge or a specific ultraviolet light, which is applied to dried air, oxygen-enriched air, or dry oxygen for maximum ozone output. During the generation process, oxygen molecules (O2) disassociate and reassemble as ozone (O3). The ozone is then drawn into the water, killing any bacteria, viruses, or mold spores that it contacts. With a half-life of approximately 20 minutes, ozone then reverts back to pure oxygen.

Related Links:

Germgard Lighting




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Automated Coagulation Analyzer
Hemolumi H6
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more

Immunology

view channel
Image: Study design for analysis of monocyte phenotype, function, and metabolism (Gráinne Jameson et al., Journal of Infection (2026). DOI: 10.1016/j.jinf.2026.106755)

Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response

Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.